Stay updated with breaking news from Devika Syamnath. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
April 26 - Intel shares slumped more than 7% premarket on Friday after a downbeat second-quarter sales forecast signaled that the boom in AI technology was diverting...
(Reuters) -AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the first quarter. The company now expects adjusted profit of between $11.13 and $11.33 per share for this year, compared with $10.97 to $11.17 estimated earlier. Analysts on average expect annual profit of $11.10 per share, according to LSEG data.
AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the first quarter. ...
Royal Caribbean Group on Thursday raised its annual profit forecast for a second time, benefiting from record demand for cruises and robust on-board spending. It now expects annual...
Shares of International Business Machines fell more than 8% in premarket trading on Thursday, as its consulting business faces pressure from enterprises tightening their budgets to cope with an...